Researcher
Irina Lambertz
- Disciplines:Paediatrics and neonatology, Molecular and cell biology, Systems biology, Nursing, Genetics
Affiliations
- Department of Pediatrics and medical genetics (Department)
Member
From1 Jan 2012 → 30 Sep 2016 - Department of Biomedical molecular biology (Department)
Member
From1 Nov 2005 → 7 Aug 2023
Projects
1 - 2 of 2
- Dual targeting of ALK and RET: establishing a novel basis for the
treatment of neuroblastomaFrom1 Jan 2015 → 30 Sep 2016Funding: FWO research project (including WEAVE projects)
- The role of the ETS transcription factor ETV5 as executer of ALK oncogenic signalingFrom1 Oct 2012 → 30 Sep 2016Funding: FWO fellowships, BOF - Other initiatives
Publications
1 - 10 of 32
- Microbes exploit death-induced nutrient release by gut epithelial cells(2021)
Authors: Christopher Anderson, Christopher B. Medina, Brady J. Barron, Laura Karvelyte, Tania Love Aaes, Irina Lambertz, Justin S. A. Perry, Parul Mehrotra, Amanda Gonçalves, Kelly Lemeire, et al.
Pages: 262 - 267 - The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness(2020)
Authors: Liselot Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, et al.
- Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice(2018)
Authors: Marjolijn Renard, Suzanne Vanhauwaert, Ali Rihani, Niels Vandamme, Pieter Van Vlierberghe, Jody J Haigh, Bieke Decaesteker, Irina Lambertz
- The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma(2017)
Authors: Irina Lambertz, Candy Kumps, Shana Claeys, Geertrui Denecker, Wouter Van Loocke, Christophe Van Neste, Jan Koster, Rogier Versteeg, Johannes Schulte
Number of pages: 1 - The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex(2017)
Authors: Shana Claeys, Geertrui Denecker, Bieke Decaesteker, Candy Kumps, Sara De Brouwer, Irina Lambertz, Annelies Fieuw, Suzanne Vanhauwaert, Kristina Althoff, Laurel Bate-Eya, et al.
Number of pages: 1 - The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma(2017)
Authors: Irina Lambertz, Candy Kumps, Shana Claeys, Geertrui Denecker, Wouter Van Loocke, Christophe Van Neste, Jan Koster, Rogier Versteeg, Johannes Schulte
Number of pages: 1 - Sensing mutant ALK: Capicua and ETV5 as executors of aberrant ALK-driven MAPK signaling(2016)
Authors: Irina Lambertz, Candy Kumps, Shana Claeys, Wouter Van Loocke, Christophe Van Neste, Jan Koster, Rogier Versteeg, Johannes Schulte
Number of pages: 1 - Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment(2015)
Authors: Irina Lambertz, Candy Kumps, Shana Claeys, Sven Lindner, Anneleen Beckers, Els Janssens, Daniel R Carter, Alex Cazes, Belamy B Cheung, Marilena De Mariano, et al.
Pages: 3327 - 3339 - The need for transparency and good practices in the qPCR literature(2013)
Authors: Stephen A Bustin, Vladimir Benes, Jeremy Garson, Jan Hellemans, Jim Huggett, Mikael Kubista, Reinhold Mueller, Tania Nolan, Michael W Pfaffl, Gregory Shipley, et al.
Pages: 1063 - 1067 - Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation(2012)
Authors: David Nittner, Irina Lambertz, Frederic Clermont, Pieter Mestdagh, Corinna Köhler, Søren Jensby Nielsen, Aart Jochemsen, Michael A Dyer, Alexander Schramm, Johannes H Schulte, et al.
Pages: 958 - 965